Humulin R
Metabolic Associated Fatty Liver Disease
University of AarhusPhase 2Active
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
3 Active assets in the Metabolic Associated Fatty Liver Disease cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Dapagliflozin Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 | BBB |
Trimetazidine October 6 University | Phase 2 | B |
SOMATOSTATIN University of Aarhus | N/A | D |
Same molecule, other indications
Humulin R is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →